Brought to you by:
Surgeons discuss early efforts rolling out SVS Branding Toolkit
Two-and-a-half years back, when Kathryn E. Bowser, MD, joined her current institution as a vascular surgeon, a confluence of unfolding events led her to a realization: “A lot of people did not understand what the modern vascular surgeon actually did.”…
SVS seeks volunteers to test website navigability
The Society for Vascular Surgery (SVS) is on the lookout for volunteers to help fine-tune a planned overhaul of vascular.org, the SVS website. Testers are required to undertake 10- to 15-minute website navigation tests before Feb. 22. The effort is…
Postmarket study of sirolimus-eluting balloon enrolls first patient
MedAlliance has announced enrollment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon Selution SLR for the treatment of patients with peripheral arterial disease (PAD). Selution SLR is a novel sirolimus-eluting balloon that provides…
Veterans study: No evidence of increased risk of death with use of PCDs out to three years
A study of more than 10,000 U.S. veterans with peripheral arterial disease (PAD) undergoing endovascular interventions in the femoropopliteal segment found that rates of two‐ and three‐year all‐cause mortality were similar among patients undergoing revascularization with a paclitaxel-coated device (PCD)…
Pioneering Duke vascular surgeon Richard McCann dies
Richard McCann, MD, a vascular surgeon who reinvented his skills after the endovascular revolution in the 1990s and implanted the first endograft for an abdominal aortic aneurysm (AAA) at Duke University in Durham, North Carolina, has died. Born in Portland,…
Evidence suggests wearable activity monitors could benefit intermittent claudication patients
There is some evidence to indicate that the inclusion of wearable activity monitors in home-based exercise therapy improves walking ability and quality of life in patients with intermittent claudication. This is the main finding of a systematic review that recently appeared…
VESAP5 pandemic discount set to end
The pandemic-induced discount applied to the fifth edition of the Vascular Educational Self-Assessment Program (VESAP5) will end March 31. VESAP5 was introduced in July 2020 at a 25% discount due to the financial difficulties caused by COVID-19. The online program—designed…
SVS opens nominations for 2021–2022 vice president
Nominations for the solitary Society for Vascular Surgery (SVS) 2021 officer position is now open. The nominations received will inform who will fill the SVS vice president role currently held by Michael C. Dalsing, MD, after the professor emeritus of…
Data show potential of Limflow system to improve outcomes for no-option CLTI
“Deep vein arterialization is safe and technically feasible,” Peter Schneider, MD, a professor in the division vascular and endovascular surgery at the University of California San Francisco, said during a recent presentation on 12-month data from the PROMISE I early…
Why VAM was shifted to August amid COVID-19 vaccination rollout
To enhance the chances of being able to hold the 2021 Vascular Annual Meeting (VAM) in-person, the Society for Vascular Surgery (SVS) has moved the conference, lock, stock and barrel to mid-August. This pre-eminent event for vascular education now will…